Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide versus duloxetine for painful chemotherapy-induced polyneuropathy
NL-OMON60073Phase 4Completed
- Sponsor
- Leiden University Medical Center
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in chemotherapy-induced peripheral neuropathy (CIPN) and Neuralgia comparing lacosamide with duloxetine (2 arms). Primary endpoint: Pain intensity score during the last 4 weeks of treatment. Started Jan 2021; status: completed.
02
Drugs
lacosamideduloxetine
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)Neuralgia
Beyond the preview
Go deeper on NL-OMON60073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60073.